← back to search

Jacob Levi

Charité - Universitätsmedizin Berlin · DE
Area of research
Economics and Econometrics · Infectious Diseases
Research interest
Research interests include Medicine, Daclatasvir, Sofosbuvir, Randomized controlled trial, Coronavirus disease 2019 (COVID-19), and Demography.
h-index
citations
207
works
3
NIH funding
primary concept
email

Recent publications

Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial
Journal of Antimicrobial Chemotherapy 2020cited by 131position: middledoi
Most new HIV infections, vertical transmissions and AIDS-related deaths occur in lower-prevalence countries
Journal of Virus Eradication 2019cited by 40position: middledoi
Analysis of Pharmacovigilance Databases for Dolutegravir Safety in Pregnancy
Clinical Infectious Diseases 2019cited by 36position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anton Pozniak · London School of Hygiene & Tropical Medicine2 papers (2019–2019) · 2 papers (2019–2020)Andrew Hill · University of Liverpool2 papers (2019–2020) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020)Nikolien S van De Ven · London School of Hygiene & Tropical Medicine1 papers (2019–2019)Amir H. Davarpanah · Emory University1 papers (2020–2020)Ali Asgari · University of Naples Federico II1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2019–2019) · 1 papers (2020–2020)Amir Reza Radmard · Aja University of Medical Sciences1 papers (2020–2020)Shahin Merat · Shariati Hospital1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2020–2020) · 1 papers (2019–2019) · 1 papers (2020–2020) · 1 papers (2020–2020)Lynne Mofenson · Elizabeth Glaser Pediatric AIDS Foundation1 papers (2019–2019)